Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial
Author:
Affiliation:
1. L. Sacco Hospital, 20157 Milano, Italy
2. Italian Institute of Telemedicine, Solbiate Arno, 21048 Varese, Italy
3. Istituto Auxologico Italiano and University of Milano-Bicocca, 20149 Milano, Italy
Abstract
Funder
Istituto Lusofarmaco d’Italia S.p.A.,
Publisher
Hindawi Limited
Subject
Internal Medicine
Link
http://downloads.hindawi.com/journals/ijhy/2015/139465.pdf
Reference46 articles.
1. Global burden of blood-pressure-related disease, 2001
2. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
3. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension
4. Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
5. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression;International Journal of Molecular Sciences;2024-03-07
2. Zofenopril: Blood pressure control and cardio-protection;Cardiology Journal;2021-09-30
3. Roles of Hydrogen Sulfide Donors in Common Kidney Diseases;Frontiers in Pharmacology;2020-11-19
4. Ambulatory blood pressure and arterial stiffness web‐based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry;The Journal of Clinical Hypertension;2019-07-11
5. Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction;Current Clinical Pharmacology;2019-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3